Transcriptional and posttranscriptional regulation of CYP1A1 by vanadium in human hepatoma HepG2 cells

Cell Biology and Toxicology

Volumn 26, Issue 5, 2010, Pages 421-434

  Abdelhamid, Ghada ^a,c   Anwar Mohamed, Anwar ^a   Badary, Osama A ^b   Moustafa, Adel A ^c   El Kadi, Ayman O S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b African Union Organization St Abbassia   (Egypt)

^c Helwan   (Egypt)

Author keywords

Aryl hydrocarbon receptor; Carcinogenesis; Cytochrome P450 1A1; Vanadium

Indexed keywords

AMMONIUM VANADATE; CYTOCHROME P450 1A1; MESSENGER RNA; VANADIUM;

ARTICLE; CANCER CELL; CATALYSIS; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REPORTER GENE; RNA EXTRACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CELL SURVIVAL; CYTOCHROME P-450 CYP1A1; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SYNTHESIS INHIBITORS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION, GENETIC; VANADATES; VANADIUM;

EID: 77957713088     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10565-010-9153-7     Document Type: Article

References (58)

1. BD Abbott MR Probst 1995 Developmental expression of two members of a new class of transcription factors: II. Expression of aryl hydrocarbon receptor nuclear translocator in the C57BL/6 N mouse embryo Dev. Dyn. 204 144 155 1:CAS:528:DyaK2MXpsVCksrs%3D 8589438
2. BD Abbott LS Birnbaum GH Perdew 1995 Developmental expression of two members of a new class of transcription factors: I. Expression of aryl hydrocarbon receptor in the C57BL/6 N mouse embryo Dev. Dyn. 204 133 143 1:CAS:528:DyaK2MXpsVCksro%3D 8589437
3. A Anwar-Mohamed AO El-Kadi 2008 Down-regulation of the carcinogen-metabolizing enzyme cytochrome P450 1a1 by vanadium Drug Metab. Dispos. 36 1819 1827 1:CAS:528:DC%2BD1cXhtVymu7rL 10.1124/dmd.108.021154 18541696
4. A Anwar-Mohamed AO El-Kadi 2009 Down-regulation of the detoxifying enzyme NAD(P)H:quinone oxidoreductase 1 by vanadium in Hepa 1c1c7 cells Toxicol. Appl. Pharmacol. 236 261 269 1:CAS:528:DC%2BD1MXksVartbw%3D 10.1016/j.taap.2009.02. 002 19367690
5. A Anwar-Mohamed AO El-Kadi 2009 Sulforaphane induces CYP1A1 mRNA, protein, and catalytic activity levels via an AhR-dependent pathway in murine hepatoma Hepa 1c1c7 and human HepG2 cells Cancer Lett. 275 93 101 1:CAS:528:DC%2BD1MXhtVeiu7o%3D 10.1016/j.canlet.2008.10.003 19013013
6. EJ Baran 2008 Vanadium detoxification: chemical and biochemical aspects Chem. Biodivers. 5 1475 1484 1:CAS:528:DC%2BD1cXhtFagu7fF 10.1002/cbdv.200890136 18729109
7. DG Barceloux 1999 Vanadium J. Toxicol. Clin. Toxicol. 37 265 278 1:CAS:528:DyaK1MXkt1Cktbc%3D 10.1081/CLT-100102425 10382561
8. EE Bessette MJ Fasco BT Pentecost LS Kaminsky 2005 Mechanisms of arsenite-mediated decreases in benzo[k]fluoranthene-induced human cytochrome P4501A1 levels in HepG2 cells Drug Metab. Dispos. 33 312 320 1:CAS:528:DC%2BD2MXisFSgsb8%3D 10.1124/dmd.104.002212 15576448
9. A Bishayee M Chatterjee 1995 Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by phenobarbital Br. J. Cancer 71 1214 1220 1:CAS:528:DyaK2MXmslCnsbg%3D 7779714
10. JA Bonzo S Chen A Galijatovic RH Tukey 2005 Arsenite inhibition of CYP1A1 induction by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin is independent of cell cycle arrest Mol. Pharmacol. 67 1247 1256 1:CAS:528:DC%2BD2MXjtFWmsLo%3D 10.1124/mol.104.006130 15630080
11. F Chen LM Demers V Vallyathan M Ding Y Lu V Castranova X Shi 1999 Vanadate induction of NF-kappaB involves IkappaB kinase beta and SAPK/ERK kinase 1 in macrophages J. Biol. Chem. 274 20307 20312 1:CAS:528:DyaK1MXks1OjsLs%3D 10.1074/jbc.274.29.20307 10400652
12. SJ Cho H Drechsler RC Burke MQ Arens W Powderly NO Davidson 2006 APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count J. Virol. 80 2069 2072 1:CAS:528:DC%2BD28XhsFagsbo%3D 10.1128/JVI.80.4.2069-2072.2006 16439564
13. MS Denison SR Nagy 2003 Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals Annu. Rev. Pharmacol. Toxicol. 43 309 334 1:CAS:528:DC%2BD3sXitFWqtr8%3D 10.1146/annurev.pharmtox.43. 100901.135828 12540743
14. J Edel E Sabbioni 1989 Vanadium transport across placenta and milk of rats to the fetus and newborn Biol. Trace Elem. Res. 22 265 275 1:CAS:528:DyaK3cXptlekug%3D%3D 10.1007/BF02916615 2484412
15. RH Elbekai AO El-Kadi 2004 Modulation of aryl hydrocarbon receptor-regulated gene expression by arsenite, cadmium, and chromium Toxicology 202 249 269 1:CAS:528:DC%2BD2cXntV2nu74%3D 10.1016/j.tox.2004.05.009 15337587
16. RH Elbekai AO El-Kadi 2007 Transcriptional activation and posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium Toxicol. Lett. 172 106 119 1:CAS:528:DC%2BD2sXosFykuro%3D 10.1016/j.toxlet.2007. 05.009 17606337
17. N Ercal H Gurer-Orhan N Aykin-Burns 2001 Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage Curr. Top Med. Chem. 1 529 539 1:CAS:528:DC%2BD3MXos1ait7s%3D 10.2174/1568026013394831 11895129
18. AM Evangelou 2002 Vanadium in cancer treatment Crit. Rev. Oncol. Hematol. 42 249 265 10.1016/S1040-8428(01)00221-9 12050018
19. N Gao M Ding JZ Zheng Z Zhang SS Leonard KJ Liu X Shi BH Jiang 2002 Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species J. Biol. Chem. 277 31963 31971 1:CAS:528: DC%2BD38XmslOqurY%3D 10.1074/jbc.M200082200 12070140
20. D Gebremedhin AR Lange TF Lowry MR Taheri EK Birks AG Hudetz J Narayanan JR Falck H Okamoto RJ Roman K Nithipatikom WB Campbell DR Harder 2000 Production of 20-HETE and its role in autoregulation of cerebral blood flow Circ. Res. 87 60 65 1:CAS:528:DC%2BD3cXkvFWju70%3D 10884373
21. CA Haiman SE Hankinson I De Vivo C Guillemette N Ishibe DJ Hunter C Byrne 2003 Polymorphisms in steroid hormone pathway genes and mammographic density Breast Cancer Res. Treat. 77 27 36 1:CAS:528:DC%2BD38XovVClt7g%3D 10.1023/A:1021112121782 12602902
22. U Hanauske AR Hanauske MH Marshall VA Muggia DD Von Hoff 1987 Biphasic effect of vanadium salts on in vitro tumor colony growth Int. J. Cell. Cloning 5 170 178 1:CAS:528:DyaL2sXlsVKru7c%3D 10.1002/stem.5530050209 3106514
23. O Hankinson 1995 The aryl hydrocarbon receptor complex Annu. Rev. Pharmacol. Toxicol. 35 307 340 1:CAS:528:DyaK2MXlt1Grurc%3D 10.1146/annurev.pa. 35.040195.001515 7598497
24. P Henklova R Vrzal J Ulrichova Z Dvorak 2008 Role of mitogen-activated protein kinases in aryl hydrocarbon receptor signaling Chem. Biol. Interact. 172 93 104 1:CAS:528:DC%2BD1cXjtVWmtLc%3D 10.1016/j.cbi.2007.12.005 18282562
25. I Jaspers JM Samet S Erzurum W Reed 2000 Vanadium-induced kappaB-dependent transcription depends upon peroxide-induced activation of the p38 mitogen-activated protein kinase Am. J. Respir. Cell Mol. Biol. 23 95 102 1:CAS:528:DC%2BD3cXlt1agtrw%3D 10873158
26. PS Kanna CB Mahendrakumar BN Indira S Srivastawa K Kalaiselvi T Elayaraja M Chatterjee 2004 Chemopreventive effects of vanadium toward 1, 2-dimethylhydrazine-induced genotoxicity and preneoplastic lesions in rat colon Environ. Mol. Mutagen. 44 113 118 1:CAS:528:DC%2BD2cXms1entLs%3D 10.1002/em.20038 15278915
27. S Khan S Liu M Stoner S Safe 2007 Cobaltous chloride and hypoxia inhibit aryl hydrocarbon receptor-mediated responses in breast cancer cells Toxicol. Appl. Pharmacol. 223 28 38 1:CAS:528:DC%2BD2sXovFKhtro%3D 10.1016/j.taap.2007. 05.010 17599377
28. H Kikuchi H Kato M Mizuno A Hossain S Ikawa J Miyazaki M Watanabe 1996 Differences in inducibility of CYP1A1-mRNA by benzimidazole compounds between human and mouse cells: evidences of a human-specific signal transduction pathway for CYP1A1 induction Arch. Biochem. Biophys. 334 235 240 1:CAS:528: DyaK28Xmt1Smtrs%3D 10.1006/abbi.1996.0451 8900397
29. JE Kim YY Sheen 2000 Inhibition of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)-stimulated Cyp1a1 promoter activity by hypoxic agents Biochem. Pharmacol. 59 1549 1556 1:CAS:528:DC%2BD3cXivVGntbg%3D 10.1016/S0006-2952(00) 00283-5 10799651
30. WK Kim YJ In JH Kim HJ Cho JH Kim S Kang CY Lee SC Lee 2006 Quantitative relationship of dioxin-responsive gene expression to dioxin response element in Hep3B and HepG2 human hepatocarcinoma cell lines Toxicol. Lett. 165 174 181 1:CAS:528:DC%2BD28Xmt1Grsbs%3D 10.1016/j.toxlet.2006.03.007 16697128
31. RJ Knox F Friedlos DA Lydall JJ Roberts 1986 Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1, 1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA Cancer Res. 46 1972 1979 1:CAS:528:DyaL28XitFyks70%3D 3512077
32. P Kopf-Maier 1987 Cytostatic non-platinum metal complexes: new perspectives for the treatment of cancer? Naturwissenschaften 74 374 382 1:STN:280:DyaL1c%2FhsVantg%3D%3D 10.1007/BF00405465 3309682
33. HM Korashy AO El-Kadi 2005 Regulatory mechanisms modulating the expression of cytochrome P450 1A1 gene by heavy metals Toxicol Sci. 88 39 51 1:CAS:528:DC%2BD2MXhtVyrtbzK 10.1093/toxsci/kfi282 16093525
34. HM Korashy AO El-Kadi 2008 Modulation of TCDD-mediated induction of cytochrome P450 1A1 by mercury, lead, and copper in human HepG2 cell line Toxicol. In Vitro 22 154 158 1:CAS:528:DC%2BD2sXhsVOksLbJ 10.1016/j.tiv.2007.08. 003 17889500
35. I Kostova 2009 Titanium and vanadium complexes as anticancer agents Anticancer Agents Med Chem 9 827 842 1:CAS:528:DC%2BD1MXhtlShu73O 19538167
36. S Krusekopf U Kleeberg AG Hildebrandt K Ruckpaul 1997 Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line Xenobiotica 27 1 9 1:CAS:528:DyaK2sXhtVOqtLo%3D 10.1080/ 004982597240721 9041675
37. HP Lipp D Schrenk T Wiesmuller H Hagenmaier KW Bock 1992 Assessment of biological activities of mixtures of polychlorinated dibenzo-p-dioxins (PCDDs) and their constituents in human HepG2 cells Arch. Toxicol. 66 220 223 1:CAS:528:DyaK38XmtVKksLw%3D 10.1007/BF01974019 1497488
38. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 402 408 1:CAS:528:DC%2BD38XhtFelt7s%3D 10.1006/meth.2001.1262 11846609
39. A Lorenzen SW Kennedy 1993 A fluorescence-based protein assay for use with a microplate reader Anal. Biochem. 214 346 348 1:CAS:528:DyaK3sXms1Gksbc%3D 10.1006/abio.1993.1504 8250247
40. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-75.
41. RA Lubet MJ Brunda D Taramelli D Dansie DW Nebert RE Kouri 1984 Induction of immunotoxicity by polycyclic hydrocarbons: role of the Ah locus Arch. Toxicol. 56 18 24 1:CAS:528:DyaL2MXlslGgsg%3D%3D 10.1007/BF00316346 6393912
42. TL Mclemore S Adelberg MC Liu NA Mcmahon SJ Yu WC Hubbard M Czerwinski TG Wood R Storeng RA Lubet, et al. 1990 Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas J. Natl. Cancer Inst. 82 1333 1339 1:STN:280:DyaK3czjvFGjtQ%3D%3D 10.1093/jnci/82.16.1333 2380990
43. BR Nechay 1984 Mechanisms of action of vanadium Annu. Rev. Pharmacol. Toxicol. 24 501 524 1:CAS:528:DyaL2cXksFelu7c%3D 10.1146/annurev.pa.24.040184. 002441 6145387
44. JVG Oscar Aparicio E Sekinger A Yang Z Moqtaderi K Struhl 2005 Chromatin Immunoprecipitation for Determining the Association of Proteins with Specific Genomic Sequences In Vivo Current Protocols in Molecular Biology 69 21.3.16 21.3.17
45. A Puga C Ma JL Marlowe 2009 The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways Biochem. Pharmacol. 77 713 722 1:CAS:528:DC%2BD1MXhs1ahtr8%3D 10.1016/j.bcp.2008.08.031 18817753
46. B Rosenberg L Vancamp JE Trosko VH Mansour 1969 Platinum compounds: a new class of potent antitumour agents Nature 222 385 386 1:CAS:528: DyaF1MXktVWquro%3D 10.1038/222385a0 5782119
47. SA Rushworth DJ Macewan 2008 HO-1 underlies resistance of AML cells to TNF-induced apoptosis Blood 111 3793 37801 1:CAS:528:DC%2BD1cXktlWmt78%3D 10.1182/blood-2007-07-104042 18202225
48. JM Samet LM Graves J Quay LA Dailey RB Devlin AJ Ghio W Wu PA Bromberg W Reed 1998 Activation of MAPKs in human bronchial epithelial cells exposed to metals Am. J. Physiol. 275 L551 L558 1:CAS:528:DyaK1cXmtFWjs78%3D 9728050
49. RP Santini S Myrand C Elferink JJ Reiners Jr 2001 Regulation of Cyp1a1 induction by dioxin as a function of cell cycle phase J. Pharmacol. Exp. Ther. 299 718 728 1:CAS:528:DC%2BD3MXnvV2qtL0%3D 11602686
50. EG Schuetz JD Schuetz MT Thompson RA Fisher JR Madariage SC Strom 1995 Phenotypic variability in induction of P-glycoprotein mRNA by aromatic hydrocarbons in primary human hepatocytes Mol. Carcinog. 12 61 65 1:CAS:528:DyaK2MXkt1agtLY%3D 10.1002/mc.2940120202 7662117
51. SA Skene IC Dewhurst M Greenberg 1989 Polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans: the risks to human health. A review Hum. Toxicol. 8 173 203 1:CAS:528:DyaL1MXksFWksLg%3D 10.1177/096032718900800301 2663703
52. MO Song JH Freedman 2005 Expression of copper-responsive genes in HepG2 cells Mol. Cell. Biochem. 279 141 147 1:CAS:528:DC%2BD2MXht1SqurnM 10.1007/s11010-005-8286-0 16283523
53. HM Stapleton JE Baker 2003 Comparing polybrominated diphenyl ether and polychlorinated biphenyl bioaccumulation in a food web in Grand Traverse Bay, Lake Michigan Arch. Environ. Contam. Toxicol. 45 227 234 1:CAS:528: DC%2BD3sXmsFGkt7k%3D 10.1007/s00244-003-0165-7 14565581
54. BG Svensson A Nilsson M Hansson C Rappe B Akesson S Skerfving 1991 Exposure to dioxins and dibenzofurans through the consumption of fish N. Engl. J. Med. 324 8 12 1:CAS:528:DyaK3MXltlCnsrk%3D 10.1056/NEJM199101033240102 1898530
55. DD Vakharia N Liu R Pause M Fasco E Bessette QY Zhang LS Kaminsky 2001 Polycyclic aromatic hydrocarbon/metal mixtures: effect on PAH induction of CYP1A1 in human HEPG2 cells Drug Metab. Dispos. 29 999 1006 1:CAS:528: DC%2BD3MXksFCntrk%3D 11408366
56. X Wang S Safe 1994 Development of an in vitro model for investigating the formation of the nuclear Ah receptor complex in mouse Hepa 1c1c7 cells Arch. Biochem. Biophys. 315 285 292 1:CAS:528:DyaK2MXisVyjurc%3D 10.1006/abbi.1994. 1502 7986070
57. R Weber C Gaus M Tysklind P Johnston M Forter H Hollert E Heinisch I Holoubek M Lloyd-Smith S Masunaga P Moccarelli D Santillo N Seike R Symons JP Torres M Verta G Varbelow J Vijgen A Watson P Costner J Woelz P Wycisk M Zennegg 2008 Dioxin- and POP-contaminated sites-contemporary and future relevance and challenges: overview on background, aims and scope of the series Environ. Sci. Pollut. Res. Int. 15 363 393 1:CAS:528:DC%2BD1cXhtFWmsLjN 10.1007/s11356-008- 0024-1 18597132
58. WM Westerink WG Schoonen 2007 Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells Toxicol. In Vitro 21 1581 1591 1:CAS:528:DC%2BD2sXhtlWrsrvN 10.1016/j.tiv.2007.05.014 17637504